Scan
To download the app
Download the Beloud app and enjoy reading the latest news, freedom of speech, and connect with the like-minds.
Download on the
App Store
Download on the
Google Play
Continue reading in...
Beloud App
Open
Safari
Continue
Sign in
Saved
Subscription
Settings
For You
Headlines
NewsStand
For You
Headlines
NewsStand
Saved
Light/Dark
Invite friends
Settings
Support
Get the app
Boursorama
@boursorama.com
·
6 hours
Follow
Merck et Daiichi retirent leur demande d'autorisation aux États-Unis pour un deuxième traitement anticancéreux
Les laboratoires Merck et Daiichi Sankyo ont annoncé le retrait de leur demande d'autorisation accélérée aux États-Unis pour l'ifinatamab deruxtecan, un traitement expérimental contre le can...
Read more Boursorama.com
Likes (0)
Dislikes (0)
Sign in
Saved
Subscription
Settings
CRM automation
Log In Or Sign Up
Sign Up Now To Get Your Own Personalized Timeline
Continue with Email
By signing up, you agreed to our
Terms of used
and
Privacy policy
, including Cookies use.
Terms of use
Privacy policy
Publishers
Contact
About us
Subscription
CRM automation
© 2022 Safe Apps
CRM automation